Skip to content

Drug interactions

Efgartigimod alfa + Golimumab

Severity: Moderate

Efgartigimod alfa and Golimumab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efgartigimod blocks the neonatal Fc receptor, which normally recycles IgG-based drugs. Golimumab is a human IgG1 antibody, so its exposure and efficacy may be reduced.

What this interaction means in plain words

Efgartigimod alfa and Golimumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Efgartigimod alfa belongs to Miscellaneous; Golimumab belongs to Musculoskeletal.

Evidence level: Moderate

Why it happens

FcRn blockade by efgartigimod increases catabolism of IgG, including IgG-based therapeutic antibodies.

What to do

Monitor for loss of golimumab effect and consider alternative therapy if long-term golimumab is essential. Consider timing doses toward the end of efgartigimod cycles.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Efgartigimod alfa and Golimumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Efgartigimod alfa with Golimumab?

MediHelp rates the interaction as moderate. Efgartigimod alfa and Golimumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efgartigimod blocks the neonatal Fc receptor, which normally recycles IgG-based drugs. Golimumab is a human IgG1 antibody, so its exposure and efficacy may be reduced.

How serious is the interaction between Efgartigimod alfa and Golimumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for loss of golimumab effect and consider alternative therapy if long-term golimumab is essential. Consider timing doses toward the end of efgartigimod cycles.

What other medicines interact with Golimumab?

MediHelp also lists interactions of Golimumab with, for example, Bcg vaccine live, Etanercept, Influenza virus vaccine quadrivalent intranasal. The full list is on the Golimumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in